Nasopharyngeal carcinoma as a paradigm of cancer genetics

Chinese Journal of Cancer

Volumn 30, Issue 2, 2011, Pages 79-84

  Simons, Malcolm J ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Simons Haplomics Limited   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER INCIDENCE; CANCER RISK; CHINA; EPSTEIN BARR VIRUS INFECTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN LEUKOCYTE ANTIGEN GENE; MONGOLOID RACE; NASOPHARYNX CARCINOMA; NONHUMAN; POPULATION MIGRATION; RISK ASSESSMENT; RISK FACTOR; TUMOR GENE; VIRUS CARCINOGENESIS;

EID: 79954558385     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10609     Document Type: Article

References (46)

1. Wee JT, Ha TC, Loong SL, et al. Is nasopharyngeal carcinoma really a Cantonese Cancer? [J]. Chin J Cancer, 2010,29(5): 517-526.
2. Turnbull D. On the trails of markers and proxies: the socio-cognitive technologies of human movement, knowledge assemblage, and their relevance to the etiology of nasopharyngeal carcinoma [J]. Chin J Cancer, 2011, 30(2): 85-95.
3. Trejaut J, Lee CL, Yen JC, et al. Ancient migration routes of Austronesian speaking populations in Oceanic Southeast Asia and Melanesia might mimic the spread of NPC [J]. Chin J Cancer, 2011,30(2):96-105.
4. Kataki AC, Simons MJ, Das AK, et al. Nasopharyngeal carcinoma in the north eastern states of India [J]. Chin J Cancer, 2011,30(2):106-113.
5. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide [M]. IARC Cancer base No. 5, version 2.0. lyon, France: IARC Press, 2004.
6. Devi BC, Pisani P, Tang TS, et al. High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island [J]. Cancer Epidemiol Biomarkers Prev, 2004,13(3):482-486.
7. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China [J]. Chin J Cancer, 2011,30(2):114-119.
8. Luo J, Chia KS, Chia SE, et al. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997 [J]. Eur J Epidemiol, 2007,22(8):513-521.
9. Ji MF, Yu YL, Cheng WM, et al. Nasopharyngeal carcinoma: early detection by serological screening and clinical examination [J]. Chin J Cancer, 2011,30(2):120-123.
10. Simons MJ, Day NE, Wee GB,et al. Nasopharyngeal carcinoma V: immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor. Cancer Res. 1974,34(5): 1192-1195.
11. Simons MJ, Wee GB, Chan SH, et al. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-B arrvirus is an etiological factor in NPC [J]. IARC Sci Publ, 1975,(11 Pt 2):249-258.
12. Simons MJ. The origin of genetic risk for nasopharyngeal carcinoma: a commentary on Is nasopharyngeal carcinoma really a 'Cantonese Cancer'? [J]. Chin J Cancer, 2010,29(5): 527-537.
13. Bei JX, Li Y, Jia WH, et al. A genomewide association study of nasopharyngeal carcinoma identifies three new susceptibility loci [J]. Nat Genet, 2010,42(7):599-603.
14. Hu SP, Day NE, Li DR, et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese [J]. Br J Cancer, 2005,92:967-970.
15. Yu KJ, Gao X, Chen CJ, et al. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan [J]. Human Immunol, 2009,70:910-914.
16. Tang M, Zeng Y, Poisson A, et al. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population [J]. Genes Immun, 2010,11:334-342.
17. Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan [J]. J Natl Cancer Inst, 2002,94:1780-1789.
18. Simons MJ, Wee GB, Chan SH, et al. Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma [J]. Lancet, 1975,1(7899):142-143.
19. Barber LD, Percival L, Valiante NM, et al. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C [J]. J Exp Med, 1996,184(2):735-740.
20. Simons MJ, Chan SH, Ou BX. Nasopharyngeal carcinoma, including analysis of HLA gene patterns in Chinese patients with cervical and hepatocellular carcinoma [M]. Simons MJ, Tait BD, eds. Proceeding of the Second Asia and Oceania Histocompatibility Workshop Conference: Immunopublishing, Publishing Division of Immunosearch Unit Trust, 445 Toorak Road, Toorak, 3142, Victoria, Australia (ISBN 0 9591744 0 0), 1983:369-378.
21. Au WY, Hawkins BR, Chan EY, et al. Association of the HLA A2-B 46-D R9 haplotype with autoimmune thyroid dysfunction after bone marrow transplantation in Chinese patients [J]. Br J Haematol, 2001,115(3):660-663.
22. Cavan DA, Penny MA, Jacobs KH, et al. The HLA association with Graves' disease is sexspecific in Hong Kong Chinese subjects [J]. Clin Endocrinol, 1994,40(1):63-66.
23. Gao SQ, Cheng X, Li Q, et al. A total of 362 HLA different haplotypes and HLA recombination haplotypes based on analysis of their family pedigree in Chinese partial Han populations [J]. Zhongguo Shi Yan Xue Za Zhi, 2009,17(3): 782-786. [in Chinese]
24. Simons MJ, Chan SH, Wee GB, et al. Nasopharyngeal carcinoma and histocompatibility antigens [J]. IARC Sci Publ, 1978,(20):271-282.
25. Varney MD, Gavrilidis A, Tait BD. Polymorphism in the regulatory regions of the HLADPB1 gene [J]. Hum Immunol, 1999,60(10):955-961.
26. Liu X, Fu Y, Liu Z, et al. An ancient balanced polymorphism in a regulatory region of human major histocompatibility complex is retained in Chinese minorities but lost worldwide [J]. Amer J Hum Genet, 2006,78(3):393-400.
27. Green RE, Krause J, Briggs AW, et al. A draft sequence of the Neandertal genome [J]. Science, 2010,328(5979):710-722.
28. Henle W, Henle G, Ho JC, et al. Antibodies to EpsteinB arr virus nasopharyngeal carcinoma, other head and neck neoplasms, and control groups [J]. J Natl Cancer Inst, 1970,44 (1):225-231.
29. Henle G, Henle W. EpsteinB arr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma [J]. Int J Cancer, 1976,17(1):1-7.
30. Guo XC, Scott K, Liu Y, et al. Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility [J]. Hum Genomics, 2006,2(6):365-375.
31. Ho JH, Huang DP, Fong YY. Salted fish and nasopharyngeal carcinoma in southern Chinese [J]. Lancet, 1978,2(8090):626.
32. Geser A, Charnay N, Day NE, et al. Environmental factors in the etiology of nasopharyngeal carcinoma: report on a case-control study in Hong Kong [J]. IARC Sci Publ, 1978,(20): 213-229.
33. Jia WH, Luo XY, Feng BJ, et al. Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China [J]. BMC Cancer, 2010,10:446.
34. Pickard A, Chen CJ, Diehl SR, et al. EpsteinB arr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan [J]. Int J Cancer, 2004,111(1):117-123.
35. Shen GP, Pan QH, Hong MH, et al. Human genetic variants of homologous recombination repair genes first found to be associated with Epstein-Barr virus antibody titers in healthy cantonese [J]. Int J Cancer, 2010, Nov 12. [Epub ahead of print]
36. Monsuur AJ, de Bakker PI, Zhernakova A, et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms [J]. PLoS One, 2008,3(5):e2270.
37. Koskinen L, Romanos J, Kaukinen K, et al. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations [J]. Immunogenetics, 2009,61 (4):247-256.
38. Day NE, Simons MJ. Disease susceptibility genes-their identification by multiple case family studies [J]. Tissue Antigens, 1976,8(2):109-119.
39. Saemundsen AK, Albeck H, Hansen JP, et al. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes [J]. Br J Cancer, 1982,46(5):721-728.
40. Jia WH, Feng BJ, Xu ZL, et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China [J]. Cancer, 2004,101(2):363-369.
41. Friborg J, Jarrett RF, Liu MY, et al. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland [J]. J Med Virol, 2007,79(12):1877-1881.
42. Boysen T, Friborg J, Andersen A, et al. The Inuit cancer pattern-the influence of migration [J]. Int J Cancer, 2008,122 (11):2568-2572.
43. Solberg OD, Mack SJ, Lancaster AK, et al. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a metaanalytic review of 497 population studies [J]. Hum Immunol, 2008,69(7):443-464.
44. Witt CS, Price P, Kaur G, et al. Common HLAB 8DR3 haplotype in Northern India is different from that found in Europe [J]. Tissue Antigens, 2002,60(6):474-480.
45. Yang H, Chen X, Wong WH. Completely phased genome sequencing through chromosome sorting [J]. Proc Nat Acad Sci U S A, 2011,108(1):12-17.
46. Fan HC, Wang J, Potanina A, et al. Whole-genome molecular haplotyping of single cells [J]. Nat Biotechnol, 2011,29(1):51-57.